SHP Stock Price - Shire PLC Stock Quote (U.K.: London) - MarketWatch

Open 3,181.50p
Day Range 3,146.00 - 3,879.50
52 Week Range 2,940.50 - 5,021.00
Market Cap £26.9B
Shares Outstanding 910.04M
Public Float 901.3M
Beta 1.01
Rev. per Employee £510.86K
P/E Ratio 10.44
EPS £3.55
Yield 1.16%
Dividend 21.46p
Ex-Dividend Date Mar 8, 2018
Short Interest n/a
% of Float Shorted n/a
Average Volume 3.43M

5 Day	21.08%
1 Month	19.09%
3 Month	-4.92%
YTD	-5.06%
1 Year	-22.59%

MarketWatch
Other Dow Jones

CORRECT: Shire rallies 17% in London as Takeda considers bidding for biopharma

Mar. 28, 2018 at 5:51 a.m. ET
by Carla Mozee

U.K. stocks rebound from 1-month low as AstraZeneca rises after trial results

Jan. 26, 2018 at 12:53 p.m. ET
by Sara Sjolin

FTSE 100 ends lower, retreating from record as home builders, retailers fall

Jan. 8, 2018 at 12:21 p.m. ET
by Carla Mozee

FTSE 100 closes at 6-week high, with U.S. tax vote on deck

Dec. 19, 2017 at 1:05 p.m. ET
by Carla Mozee

Shire's stock falls after drug trial misses primary and secondary endpoints

Dec. 19, 2017 at 7:39 a.m. ET
by Tomi Kilgore

Opinion

Why your doctor may soon have you playing video games

Dec. 5, 2017 at 2:57 a.m. ET
by Silvia Ascarelli

FTSE 100 ends slightly higher, posts record close

Nov. 3, 2017 at 1:19 p.m. ET
by Carla Mozee

Fund manager, analysts make the case for this ‘loathed’ pharma stock

Oct. 30, 2017 at 5:49 a.m. ET
by Victor Reklaitis

This billion-dollar dry eye drug is behind Allergan’s controversial patent deal

Oct. 14, 2017 at 12:05 p.m. ET
by Emma Court

U.K. stocks end lower as strong inflation reading boosts pound

Sep. 12, 2017 at 12:32 p.m. ET
by Carla Mozee

Leon Cooperman's stock picks at Delivering Alpha turn in mixed performance

Sep. 12, 2017 at 10:41 a.m. ET
by Sue Chang

Opinion

How investors should play gene-therapy stocks

Sep. 6, 2017 at 9:13 p.m. ET
by Ethan Lovell

FTSE 100 slips as renewed U.S.-North Korea tensions prompt caution

Aug. 21, 2017 at 12:09 p.m. ET
by Carla Mozee

U.K. stocks rise for 2nd straight day as pound falters on softer-than-expected inflation

Aug. 15, 2017 at 11:59 a.m. ET
by Sara Sjolin

FTSE 100 finishes with fourth straight loss as oil worries linger

Jun. 23, 2017 at 12:48 p.m. ET
by Carla Mozee

FTSE 100 trims losses into the close as oil rises

Jun. 22, 2017 at 12:17 p.m. ET
by Carla Mozee

FTSE 100 ends lower as oil prices fall, pound climbs on rate-hike hopes

Jun. 21, 2017 at 12:40 p.m. ET
by Carla Mozee

FTSE 100 ends lower as pound hits highest level in nearly 8 months

May. 18, 2017 at 12:12 p.m. ET
by Carla Mozee

Shire ADRs jump almost 7% premarket after positive trial of Angioedema treatment

May. 18, 2017 at 7:18 a.m. ET
by Ciara Linnane

Shire reports positive results in trial of treatment for hereditary angioedema

May. 18, 2017 at 7:02 a.m. ET
by Ciara Linnane

Sterling, Bond Yields Tumble on BOE Rate Rise

Nov. 2, 2017 at 1:20 p.m. ET
on The Wall Street Journal

Big Pharma’s Price Problem -- Heard on the Street

Apr. 2, 2015 at 5:38 p.m. ET
on The Wall Street Journal

Bidding War Yields Rich Price for Biotech

Mar. 5, 2015 at 7:49 p.m. ET
on The Wall Street Journal

AbbVie’s Expensive Growth Tonic -- Heard on the Street

Mar. 5, 2015 at 2:50 p.m. ET
on The Wall Street Journal

Valeant Nears Deal to Buy Salix

Feb. 22, 2015 at 1:56 p.m. ET
on The Wall Street Journal

Shire Can Make NPS the Right Treatment--Heard on the Street

Jan. 12, 2015 at 7:06 a.m. ET
on The Wall Street Journal

Chiquita Shareholders Reject Banana Merger

Oct. 24, 2014 at 11:16 a.m. ET
on The Wall Street Journal

Shire Raises Earnings Guidance After Record Sales Growth

Oct. 24, 2014 at 11:02 a.m. ET
on The Wall Street Journal

Misery Widespread at Hedge Funds

Oct. 20, 2014 at 10:44 p.m. ET
on The Wall Street Journal

AbbVie Flip-Flop Hands U.S. Government Tax-Deal Victory

Oct. 16, 2014 at 12:36 a.m. ET
on The Wall Street Journal

Shire Says It Waives Three-Day Notice Period for AbbVie Board Meeting

Oct. 15, 2014 at 2:30 p.m. ET
on The Wall Street Journal

Steris to Buy Synergy Health for $1.9 Billion

Oct. 13, 2014 at 8:05 a.m. ET
on The Wall Street Journal

Valeant, Pershing Square to Boost Allergan Bid

Oct. 7, 2014 at 7:10 p.m. ET
on The Wall Street Journal

Salix, Cosmo Cancel Merger Agreement

Oct. 3, 2014 at 4:22 a.m. ET
on The Wall Street Journal

European Stocks Tumble on Eurozone Fears

Sep. 23, 2014 at 12:18 p.m. ET
on The Wall Street Journal

Corporate Watch: News Digest

Sep. 2, 2014 at 8:50 a.m. ET
on The Wall Street Journal

Treasury Prepares Options to Address Tax Inversions

Aug. 18, 2014 at 1:20 p.m. ET
on The Wall Street Journal

Three Ways Investors Can Play the 'Inversion' Boom

Jul. 29, 2014 at 4:10 p.m. ET
on The Wall Street Journal

HEARD ON THE STREET: Taxing Terms in AbbVie's Shire Deal

Jul. 18, 2014 at 11:28 a.m. ET
on The Wall Street Journal

Italy's GTECH to Buy Casino-Equipment Maker IGT

Jul. 16, 2014 at 2:39 p.m. ET
on The Wall Street Journal

Other News
Press Releases

Sterling, Bond Yields Tumble on BOE Rate Rise

Nov. 2, 2017 at 1:20 p.m. ET
on The Wall Street Journal

Big Pharma’s Price Problem -- Heard on the Street

Apr. 2, 2015 at 5:38 p.m. ET
on The Wall Street Journal

Bidding War Yields Rich Price for Biotech

Mar. 5, 2015 at 7:49 p.m. ET
on The Wall Street Journal

AbbVie’s Expensive Growth Tonic -- Heard on the Street

Mar. 5, 2015 at 2:50 p.m. ET
on The Wall Street Journal

Valeant Nears Deal to Buy Salix

Feb. 22, 2015 at 1:56 p.m. ET
on The Wall Street Journal

Shire Can Make NPS the Right Treatment--Heard on the Street

Jan. 12, 2015 at 7:06 a.m. ET
on The Wall Street Journal

Chiquita Shareholders Reject Banana Merger

Oct. 24, 2014 at 11:16 a.m. ET
on The Wall Street Journal

Shire Raises Earnings Guidance After Record Sales Growth

Oct. 24, 2014 at 11:02 a.m. ET
on The Wall Street Journal

Misery Widespread at Hedge Funds

Oct. 20, 2014 at 10:44 p.m. ET
on The Wall Street Journal

AbbVie Flip-Flop Hands U.S. Government Tax-Deal Victory

Oct. 16, 2014 at 12:36 a.m. ET
on The Wall Street Journal

Shire Says It Waives Three-Day Notice Period for AbbVie Board Meeting

Oct. 15, 2014 at 2:30 p.m. ET
on The Wall Street Journal

Steris to Buy Synergy Health for $1.9 Billion

Oct. 13, 2014 at 8:05 a.m. ET
on The Wall Street Journal

Valeant, Pershing Square to Boost Allergan Bid

Oct. 7, 2014 at 7:10 p.m. ET
on The Wall Street Journal

Salix, Cosmo Cancel Merger Agreement

Oct. 3, 2014 at 4:22 a.m. ET
on The Wall Street Journal

European Stocks Tumble on Eurozone Fears

Sep. 23, 2014 at 12:18 p.m. ET
on The Wall Street Journal

Corporate Watch: News Digest

Sep. 2, 2014 at 8:50 a.m. ET
on The Wall Street Journal

Treasury Prepares Options to Address Tax Inversions

Aug. 18, 2014 at 1:20 p.m. ET
on The Wall Street Journal

Three Ways Investors Can Play the 'Inversion' Boom

Jul. 29, 2014 at 4:10 p.m. ET
on The Wall Street Journal

HEARD ON THE STREET: Taxing Terms in AbbVie's Shire Deal

Jul. 18, 2014 at 11:28 a.m. ET
on The Wall Street Journal

Italy's GTECH to Buy Casino-Equipment Maker IGT

Jul. 16, 2014 at 2:39 p.m. ET
on The Wall Street Journal

Shire and NanoMedSyn Enter Into Research Agreement for Potential Lysosomal Storage Disorder Treatment

Mar. 26, 2018 at 2:00 a.m. ET
on Globe Newswire

Shire plc : New Data Presented at the Endocrine Society's 2018 Annual Meeting Advances Understanding of the Rare Disease Chronic Hypoparathyroidism

Mar. 20, 2018 at 3:00 a.m. ET
on Globe Newswire

Shire to Highlight Advancements in Chronic Hypoparathyroidism Research at the Endocrine Society's 2018 Annual Meeting

Mar. 12, 2018 at 3:00 a.m. ET
on Globe Newswire

Caladrius Biosciences Acquires an Exclusive License to a Late Stage CD34+ Cell Therapy Program for the Treatment of Refractory Angina

Mar. 6, 2018 at 8:00 a.m. ET
on GlobeNewswire

The EMA Grants Accelerated Assessment for Shire's Lanadelumab Being Evaluated for the Prevention of Attacks in HAE Patients Aged 12 Years and Older

Feb. 27, 2018 at 11:19 a.m. ET
on Globe Newswire

Shire Recognizes Rare Disease Day 2018 with Global Initiatives Focused on Reducing the Time to Diagnosis

Feb. 22, 2018 at 7:00 a.m. ET
on Globe Newswire

Shire plc : Final Results

Feb. 14, 2018 at 7:00 a.m. ET
on Globe Newswire

AB Biosciences and Shire Enter Into Agreement for Development and Commercialization of AB Biosciences' PRIM Program

Jan. 30, 2018 at 7:00 a.m. ET
on Globe Newswire

FDA Grants Approval to Shire for Technology Transfer of CINRYZE(R) Drug Product Manufacturing Process to Vienna, Austria Manufacturing Site

Jan. 24, 2018 at 6:00 a.m. ET
on Globe Newswire

Shire Announces Business Update at 36th Annual J.P. Morgan Healthcare Conference

Jan. 8, 2018 at 9:30 a.m. ET
on Globe Newswire

Shire plc : Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for Cytomegalovirus (CMV) Infection in Transplant Patients

Jan. 4, 2018 at 7:01 a.m. ET
on GlobeNewswire

Shire to present at the 36th Annual J.P. Morgan Healthcare Conference

Jan. 4, 2018 at 7:00 a.m. ET
on Globe Newswire

Shire files for FDA approval of a new plasma manufacturing facility in Covington, Georgia to support growing Immunology franchise

Dec. 27, 2017 at 7:01 a.m. ET
on GlobeNewswire

Shire files for FDA approval of a new plasma manufacturing facility in Covington, Georgia to support growing Immunology franchise

Dec. 27, 2017 at 7:00 a.m. ET
on Globe Newswire

Shire plc : Novel Clinical Study Collaboration Announced Designed to Improve Clinical Care for Hemophilia Patients through Innovative Personalized Treatment

Dec. 14, 2017 at 7:01 a.m. ET
on GlobeNewswire

Shire plc : New Formulation of ONCASPAR(R) (pegaspargase) Receives Marketing Authorization in Europe for Patients with Acute Lymphoblastic Leukemia (ALL)

Dec. 13, 2017 at 2:26 a.m. ET
on Globe Newswire

Shire and Rani Therapeutics Enter into Collaboration to Evaluate Use of the Rani Pill(TM) Technology for the Oral Delivery of Factor Therapy

Dec. 5, 2017 at 7:00 a.m. ET
on Globe Newswire

Shire Appoints Andreas Busch, Ph D as Head of Research and Development and Chief Scientific Officer

Dec. 1, 2017 at 3:01 a.m. ET
on Globe Newswire

U.S. FDA Grants Shire Orphan Drug Designation for Investigational Anti-MAdCAM Antibody SHP647 for the Treatment of Moderately to Severely Active Ulcerative Colitis in Pediatric Patients

Nov. 30, 2017 at 7:00 a.m. ET
on Globe Newswire

Shire plc : Directorate change

Nov. 20, 2017 at 8:01 a.m. ET
on Globe Newswire

Shire Plc is a biopharmaceutical company. It engaged in the research, development, licensing, manufacturing, marketing, distribution and sale of medicines to meet significant unmet patient needs. The company's products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr and foznol. Shire was founded in 1986 and is headquartered in Dublin, Ireland. (See Full Profile)

Sell
Under
Hold
Over
Buy

Number of Ratings 28 Full Ratings

Name	Chg %	Market Cap
Pfizer Inc.	-1.03%	kr1.71T
AstraZeneca PLC	0.38%	£60.28B
GlaxoSmithKline PLC	0.92%	£63.88B
Hikma Pharmaceuticals PLC	-0.26%	£2.78B

Competitor Data Provided By

Dow	23,857.71	-344.89	-1.43%
S&P 500	2,612.62	-45.93	-1.73%
Nasdaq	7,008.81	-211.74	-2.93%
GlobalDow	3,000.35	-21.80	-0.72%
Gold	1,345.20	-2.70	-0.20%
Oil	64.59	-0.66	-1.01%

Shire PLC

p 3,701.00

Customize MarketWatch

No Items in Watchlist

No Saved Watchlists

Uh oh

No Recent Tickers

CORRECT: Shire rallies 17% in London as Takeda considers bidding for biopharma

Shire reports positive results in trial of treatment for hereditary angioedema

Stocks

Columns

Authors

Topics

^p 3,701.00